GLPwatch
Trials (2101)
Page 12 of 36.
- GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
- Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
- Tirzepatide in the Treatment of Cannabis Use Disorder
- A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
- Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)
- A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
- Exenatide For Reducing the Reinforcing Effects of Cocaine
- Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
- Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)
- Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
- A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
- Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
- Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
- Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
- iGlarLixi CGM Study in Chinese T2D Individuals After OADs
- Incretin-based Drugs and Pancreatic Cancer
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
- A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
- Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
- A Phase I Study of LY3502970 in Healthy Participants
- Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
- A Study of LY3502970 in Participants With Type 2 Diabetes
- The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- Effect of GLP-1 on Angiogenesis
- Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
- Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
- Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
- Fibrosis Lessens After Metabolic Surgery
- Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
- A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
- A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
- Semaglutide to Reduce Atrial Fibrillation Burden
- Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
- MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
- Semaglutide for Alcohol Use Disorder
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
- Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
- Exeantide in Type 2 Diabetes on Insulin
- Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
- Comparison of Two Liraglutide Formulations in Healthy Subjects
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
- A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
- Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
- Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
- A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)
- SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes